Compare Equinix Inc (EQIX) vs McKesson Corporation (MCK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Equinix Inc vs McKesson Corporation — how do they compare? Equinix Inc trades at $1,032.41 (market cap $101.87B), while McKesson Corporation trades at $898 (market cap $105.14B). The key difference: Equinix Inc and McKesson Corporation are close in size by market cap, and Equinix Inc pays the higher dividend (2%). Which is the better fit depends on your goals.
| EQIX | MCK | |
|---|---|---|
Market Cap | $101.87B | $105.14B |
Sector | Real Estate | Health |
52-Week High | $1.12K | $995.69 |
52-Week Low | $726.09 | $659.01 |
Enterprise Value | $123.00B | $111.67B |
Dividend Yield | 2% | 0.42% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Equinix Inc
Equinix is a retail provider of data centers, enabling hundreds of enterprise tenants to house their servers and networking equipment in a collocated environment. Tenants can then connect with each other, through cloud service providers and telecom networks. Equinix operates 240 data centers in 66 markets worldwide and owns just less than half of them. The firm has roughly 10,000 customers, including 2,000 networks, that are dispersed over five verticals: Cloud and IT Services, Content Providers, Network and Mobile Services, Financial Services, and Enterprise. About 70% of Equinix's revenue comes from renting space to tenants and related services, and more than 15% comes from connecting customers with each other. Equinix operates as a real estate investment trust.
Read more on EQIX →About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →
